Escolar Documentos
Profissional Documentos
Cultura Documentos
Results were above our estimate, with EBIDTA at Rs17.9bn Previous Reco Accumulate Target Price Rs.449
-3.8/5.3 -11.9 5,046 16,752
and PAT at Rs10.9bn. Subsidy payout for Q3FY12 grew by 28% YoY to Rs5.3bn
EPS change FY11E/12E (%) Target Price change (%) Nifty Sensex
Rs10bn, While trading business grew by 38% to Rs.82.7bn YoY, mainly on the back of higher spot LNG volume marginally by 0.3% to 119mmscmd and 1.2% to 85mmscmd respectively, mainly driven by higher offtake of spot LNG which is to be decided by PNGRB would keep the stock under pressure until any clarity emerges. Maintain accumulate with TP of Rs.449
Price Performance
(%) Absolute Rel. to Nifty
Source: Bloomberg
1M (5)
440
410
380
-4
GAIL reported results which were inline with our estimates. Revenue for the quarter was at Rs.112.9bn, growth of 35% YoY, mainly due to better performance from petrochemical, Transmission and trading segment. EBITDA during the quarter was at Rs17.9bn, growth of 34.6%, YoY. During the quarter the company reported net profit of Rs10.9bn, growth of 12.8% YoY. Subsidy payout stood at Rs.5.3bn growth of 28% YoY, mainly due to higher crude oil prices compared to previous year.
350 Jan-11
Mar-11
May-11
Gail (India) (LHS)
Jul-11
Sep-11
Nov-11
-10 Jan-12
Better performance from Transmission and Trading segment drives the revenue and profitability in Q3 FY12
Revenue has increased by 35% to Rs112.9bn in Q3 FY12, mainly due to higher volume growth and higher realisation in both Transmission and Trading segment on the back of higher spot LNG offtake. During the quarter company has imported 4 LNG cargos. Transmission revenue grew by 0.3% to Rs.10bn, while volume and realisation grew by 0.3% to 119mmscmd and 9.4% to Rs.0.91/scm, QoQ respectively. While Trading revenue jumped 22.8% QoQ to Rs.82.6bn. Trading volume for the quarter stood at 85mmscmd against 84mmscmd sequentially. We believe transmission volume for Q4 FY12 would be around 119-121mmscmd.
Source: Bloomberg
Stock Details
Sector Bloomberg Equity Capital (Rs mn) Face Value (Rs) No of shares o/s (mn) 52 Week H/L (Rs) Market Cap (Rs bn/USD mn) Daily Avg Vol (No of shares) Daily Avg Turnover (US$ mn) Oil & Gas GAIL@IN 12685 10 1268 486/360 469/9,358 1239816 9.6
Petchem and LPG & LHC volume decline by 5% and 12% sequentially, on the back of plan shut down during the quarter.
During the quarter petchem and LPG & LHC volume declined by 5% to 0.359mnt and 12% to 0.113mnt QoQ mainly due to plan shutdown during the quarter. However realisation for both petrochemical and LPG segment grew by 6.8% to Rs.76.8/kg and 2.9% to Rs.26.9/kg.
Financial Snapshot
YEMar FY10A FY11E FY12E FY13E Net Sales 249964 326690 404338 448109 EBITDA (Core) 46276 54000 61604 62285 (%) 18.5 16.6 15.2 13.9 APAT 31391 35611 37595 38512 EPS (Rs) 24.7 28.1 29.6 30.4 EPS % chg 12.0 13.4 5.6 2.4 RoE (%) 19.9 19.7 18.1 16.5 P/E 14.9 13.1 12.4 12.1 EV/ EBITDA 9.1 8.6 8.1 8.9
(Rs.mn)
P/BV 2.8 2.4 2.1 1.9
Dhaval Joshi dhaval.joshi@emkayglobal.com +91 22 6612 1282 Jagdish Meghnani jagdish.meghnani@emkayglobal.com +91 22 6612 1285
Result Update
GAIL Ltd
Result Update
9M FY11 236276 193828 82.0% 173282 73.3% 4776 2.0% 15770 6.7% 42448 4831 37617 3882 487 41012 13230 27782 0 27782 0 27782 22
YoY (%) 26.6 28.3 28.8 16.1 26.7 18.9 19.3 18.9 -48.0 31.6 12.4 8.7 14.1 14.1 14.1 14.1 (bps)
Revised estimates
We have tweaked our estimates marginally for FY12E & FY13E based on the higher under recovery assumption.
FY12E Rs bn Sales EBIDTA % margin PAT EPS Old 376.6 63.9 17.0 39.0 30.8 New 405.1 61.6 15.2 37.6 29.6 %Chg 7.6 -3.6 -176.1 -3.6 -3.8 Old 432.2 69.7 16.1 40.7 32.1 FY13E New 448 62.3 13.9 38.5 30.4 %Chg 3.7 -10.6 -222.1 -5.4 -5.3
Emkay Research
24 January 2012
GAIL Ltd
Result Update
mmscmd
Volume
Source: Company, Emkay Research
% Grow th
Rs/Scm
Tranmission tariff
% Grow th
Q3 FY11
Q4FY11
Subsidy Payout
As % of Upstream
Emkay Research
24 January 2012
GAIL Ltd
Result Update
Key Financials
Income statement
Y/E Mar (Rsmn) Net Sales Growth (%) Expenditure Materials Consumed Employee Cost Other Exp EBITDA Growth (%) EBITDA margin (%) Depreciation EBIT EBIT margin (%) Other Income Interest expenses PBT Tax Effective tax rate (%) Adjusted PAT Growth (%) Net Margin (%) (Profit)/loss from JVs/Ass/MI Adjusted PAT AfterJV/ MI E/O items Reported PAT PAT after MI Growth (%) FY10A 249964 5.1 203688 166612 6212 30864 46276 14.5 18.5 5618 40658 18.6 5411 830 45778 14386 31.4 31391 12.0 12.6 0 31391 0 31391 31391 12.0 FY11E 326690 30.2 271366 241847 7527 21992 54000 16.7 16.6 6503 47497 16.4 4407 829 52400 16789 32.0 35611 13.4 10.9 0 35611 0 35611 35611 13.4 FY12E 404338 24.5 343413 308626 7716 27071 61604 14.1 15.2 7902 53702 13.8 2725 867 54882 17287 31.5 37595 5.6 9.3 0 37595 0 37595 37595 5.6 FY13E 448109 10.6 385824 351275 8111 26438 62285 1.1 13.9 9376 52909 12.8 4619 1114 56412 17883 31.7 38529 2.5 8.6 0 38529 0 38529 38529 2.5
Balance Sheet
Y/E Mar (Rsmn) Equity share capital Reserves & surplus Net worth Minority Interest Secured Loans Unsecured Loans Loan Funds Net deferred tax liability Total Liabilities Gross Block Less: Depreciation Net block Capital work in progress Investment Current Assets Inventories Sundry debtors Cash & bank balance Loans & advances Other current assets Current lia & Prov Current liabilities Provisions Net current assets Misc. exp Total Assets FY10A 12685 155305 167990 0 14460 344 14804 13896 196689 210377 91066 119311 23305 20730 137127 6317 12950 41716 76062 83 103784 54483 49301 33344 0 196690 FY11E 12685 180527 193211 0 37460 1344 38804 13896 245911 250377 97569 152808 48836 20730 142183 7602 16268 24537 92961 813 118645 64206 54439 23538 0 245911 FY12E 12685 209216 221900 0 72708 2344 75052 13896 310848 305377 105471 199906 69417 20730 172392 8336 20251 27074 115719 1013 151595 82739 68856 20797 0 310848 FY13E 12685 231211 243896 0 121665 3344 125009 13896 382800 385377 114846 270530 78614 20730 183438 13815 20369 20102 128031 1120 170508 93115 77393 12930 0 382800
Cash Flow
Y/E Mar (Rsmn) PBT (Ex-Other income) Depreciation Interest Provided Other Non-Cash items Chg in working cap Tax paid Operating Cashflow Capital expenditure Free Cash Flow Other income Investments Investing Cashflow Equity Capital Raised Loans Taken / (Repaid) Interest Paid Dividend paid (incl tax) Income from investments Others Financing Cashflow Net chg in cash Opening cash position Closing cash position FY10A 45785 5619 700 -2110 12454 15686 46761 -35702 11060 4897 -3358 -34162 0 2803 -841 -7420 0 0 -5459 7140 34575 41716 FY11E 52400 6503 829 0 -7373 16789 35570 -65531 -29961 0 0 -65531 0 24000 -829 -10389 0 0 12783 -17178 41716 24537 FY12E 54882 7902 867 0 5277 17287 51640 -75581 -23941 0 0 -75581 0 36248 -867 -8905 0 0 26477 2536 24537 27074 FY13E 56388 9376 1138 0 896 17876 49923 -89197 -39274 0 0 -89197 0 49957 -1138 -16516 0 0 32303 -6971 27074 20102
Key Ratios
Y/E Mar Profitability (%) EBITDA Margin Net Margin ROCE ROE RoIC Per Share Data (Rs) EPS CEPS BVPS DPS Valuations (x) PER P/CEPS P/BV EV / Sales EV / EBITDA Dividend Yield (%) Gearing Ratio (x) Net Debt/ Equity Net Debt/EBIDTA Working Cap Cycle (days) -0.3 -1.0 -51.4 0.0 -0.1 -45.2 0.1 0.5 -48.8 0.4 1.4 -48.0 14.9 12.6 2.8 1.7 9.1 2.0 13.1 11.1 2.4 1.4 8.6 1.9 12.4 10.3 2.1 1.2 8.1 1.6 12.1 9.7 1.9 1.2 8.9 1.6 24.7 29.2 132.4 7.5 28.1 33.2 152.3 7.0 29.6 35.9 174.9 6.0 30.4 37.8 192.3 6.0 18.5 12.6 25.1 19.9 38.0 16.6 10.9 24.1 19.7 35.3 15.2 9.3 20.0 18.1 30.5 13.9 8.6 16.6 16.5 22.8 FY10A FY11E FY12E FY13E
Emkay Research
24 January 2012
GAIL Ltd
Result Update
Emkay Global Financial Services Ltd. 7th Floor, The Ruby, Senapati Bapat Marg, Dadar - West, Mumbai - 400028. India Tel: +91 22 66121212 Fax: +91 22 66121299 Web: www.emkayglobal.com
Emkay Global Financial Services Limited and its affiliates are a full-service, brokerage, investment banking, investment management, and financing group. We along with our affiliates are participants in virtually all securities trading markets in India. Our research professionals provide important input into our investment banking and other business selection processes. Investors may assume that Emkay Global Financial Services Limited and/or its affiliates may seek investment banking or other business from the company or companies that are the subject of this material and that the research professionals who were involved in preparing this material may participate in the solicitation of such business. Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest. Additionally, other important information regarding our relationships with the company or companies that are the subject of this material is provided herein. This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject Emkay Global Financial Limited or its group companies to any registration or licensing requirement within such jurisdiction. Specifically, this document does not constitute an offer to or solicitation to any U.S. person for the purchase or sale of any financial instrument or as an official confirmation of any transaction to any U.S. person unless otherwise stated, this message should not be construed as official confirmation of any transaction. No part of this document may be distributed in Canada or used by private customers in United Kingdom. All material presented in this report, unless specifically indicated otherwise, is under copyright to Emkay. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of Emkay. All trademarks, service marks and logos used in this report are trademarks or registered trademarks of Emkay or its Group Companies. The information contained herein is not intended for publication or distribution or circulation in any manner whatsoever and any unauthorized reading, dissemination, distribution or copying of this communication is prohibited unless otherwise expressly authorized. Please ensure that you have read Risk Disclosure Document for Capital Market and Derivatives Segments as prescribed by Securities and Exchange Board of India before investing in Indian Securities Market. In so far as this report includes current or historic information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed.
DISCLAIMER:
Emkay Research
24 January 2012
www.emkayglobal.com 1